Leigong Teng Duo Gan Pian Leigongtengduogan Pian Leigongteng Duogan Pian Leigongteng Duogan Tablets Lei Gong Teng Duo Gan Pian Thunder God Vine Tablets Tripterygium wilfordii glycoside tablets for rheumatoid arthritis, nephrotic syndrome etc.

NAMES

Leigong Teng Duo Gan Pian

Leigongtengduogan Pian

Leigongtengduogan Tablets

Leigongteng Duogan Pian

Leigongteng Duogan Tablets

Lei Gong Teng Duo Gan Pian

Lei Gong Teng Duo Gan Tablets

Thunder God Vine Tablets

Tripterygium wilfordii glycoside tablets

Tripterygium Wilfordii Hook. F. Tablets

Tripterygium Glycosides Tablets

雷公藤多苷片

Tripterygium Glycosides Tablets Package Insert

Please read the instructions carefully and use under the supervision of a physician.

Warning:

Tripterygium preparations may cause adverse reactions involving multiple system damages. Strictly follow the instructions and use under physician guidance.

Drug Information

Generic Name: Tripterygium Glycosides Tablets

Chinese Pinyin: Léigōngténg Duōgān Piàn

Active Ingredient: Tripterygium glycosides.

Description:

Light yellow to brownish-yellow tablets with a slightly bitter and astringent taste.

Indications:

Dispels wind, detoxifies, eliminates dampness, reduces swelling, and relaxes tendons to promote circulation. Exhibits anti-inflammatory, cellular, and humoral immunosuppressive effects. Used for rheumatoid arthritis, nephrotic syndrome, Behçet's triad, leprosy reactions, autoimmune hepatitis, and other conditions caused by obstruction of wind-heat-toxicity-dampness pathogens.

Specification: 10 mg per tablet.

Dosage and Administration:

Oral administration. 1–1.5 mg/kg daily, divided into three doses taken after meals, or as directed by the physician.

Adverse Reactions

Digestive System: Dry mouth, nausea, vomiting, fatigue, loss of appetite, abdominal distension, diarrhea, jaundice, elevated transaminases; severe cases may include acute toxic liver injury or gastric hemorrhage.

Hematologic System: Leukopenia, thrombocytopenia; severe cases may lead to agranulocytosis or pancytopenia.

Urinary System: Oliguria, polyuria, edema, renal dysfunction; severe cases may result in acute renal failure.

Cardiovascular System: Palpitations, chest tightness, arrhythmia, hypertension or hypotension, ECG abnormalities.

Reproductive/Endocrine System: Menstrual disorders, oligomenorrhea, or amenorrhea in women; reduced sperm count and motility in men.

Nervous System: Dizziness, drowsiness, insomnia, neuritis, diplopia.

Others: Rash, pruritus, alopecia, facial pigmentation.

Contraindications

Forbidden in children, individuals of childbearing age with pregnancy plans, pregnant or lactating women.

Contraindicated in patients with cardiac, hepatic, or renal dysfunction; severe anemia; leukopenia; or thrombocytopenia.

Prohibited during active gastric or duodenal ulcers.

Not for use in patients with severe arrhythmias.

Precautions

Use strictly at prescribed doses under physician supervision. Do not exceed recommended dosage.

Regular follow-up monitoring of blood/urine tests, ECG, and liver/kidney function is required during treatment. Discontinue if necessary and manage symptoms accordingly.

Continuous use should generally not exceed 3 months. Extension requires physician evaluation based on patient condition.

Storage

Store sealed, protected from light, and in a dry place.

Packaging: Plastic bottle, 50 tablets/bottle.

Shelf Life: 60 months.

Standard: National Drug Standard WS3-B-3350-98-2011.

Approval No.: National Drug Approval Z32021007.

Marketing Authorization Holder & Manufacturer

Jiangsu Meitong Pharmaceutical Co., Ltd.

Address: No. 16, Peilan Road, Taizhou, Jiangsu, China

Postal Code: 225300

Tel: 0523-8655 6630 / 8655 5899

Fax: 0523-8657 4811

For inquiries, please contact the manufacturer.